These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 25313253

  • 1. Efficacy of polyspecific intravenous immunoglobulin therapy in streptococcal toxic shock syndrome.
    Arends JE, Harkisoen S.
    Clin Infect Dis; 2015 Jan 15; 60(2):324. PubMed ID: 25313253
    [No Abstract] [Full Text] [Related]

  • 2. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
    Perez CM, Kubak BM, Cryer HG, Salehmugodam S, Vespa P, Farmer D.
    Am J Med; 1997 Jan 15; 102(1):111-3. PubMed ID: 9209207
    [No Abstract] [Full Text] [Related]

  • 3. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J, Söderquist B, Normark BH, Norrby-Teglund A.
    Clin Infect Dis; 2004 Mar 15; 38(6):836-42. PubMed ID: 14999628
    [Abstract] [Full Text] [Related]

  • 4. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.
    Stevens DL.
    Clin Infect Dis; 1998 Mar 15; 26(3):639-41. PubMed ID: 9524836
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics.
    Chiu CH, Ou JT, Chang KS, Lin TY.
    Infection; 1997 Mar 15; 25(1):47-8. PubMed ID: 9039540
    [No Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
    Linnér A, Darenberg J, Sjölin J, Henriques-Normark B, Norrby-Teglund A.
    Clin Infect Dis; 2014 Sep 15; 59(6):851-7. PubMed ID: 24928291
    [Abstract] [Full Text] [Related]

  • 8. Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.
    Lamothe F, D'Amico P, Ghosn P, Tremblay C, Braidy J, Patenaude JV.
    Clin Infect Dis; 1995 Dec 15; 21(6):1469-70. PubMed ID: 8749635
    [Abstract] [Full Text] [Related]

  • 9. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
    Norrby-Teglund A, Low DE, McGeer A, Kotb M.
    Adv Exp Med Biol; 1997 Dec 15; 418():563-6. PubMed ID: 9331714
    [No Abstract] [Full Text] [Related]

  • 10. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Abinun M, Cant AJ.
    Lancet; 1994 Jan 29; 343(8892):300. PubMed ID: 7905129
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dilemmas in the treatment of invasive Streptococcus pyogenes infections.
    Stevens DL.
    Clin Infect Dis; 2003 Aug 01; 37(3):341-3. PubMed ID: 12884157
    [No Abstract] [Full Text] [Related]

  • 14. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.
    Schlievert PM.
    J Allergy Clin Immunol; 2001 Oct 01; 108(4 Suppl):S107-10. PubMed ID: 11586276
    [Abstract] [Full Text] [Related]

  • 15. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.
    Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A, StreptIg Study Group.
    Clin Infect Dis; 2003 Aug 01; 37(3):333-40. PubMed ID: 12884156
    [Abstract] [Full Text] [Related]

  • 16. Immunoglobulin therapy in non-menstrual streptococcal toxic shock syndrome.
    Murthy BV, Nelson RA, Mannion PT.
    Anaesth Intensive Care; 2003 Jun 01; 31(3):320-3. PubMed ID: 12879681
    [Abstract] [Full Text] [Related]

  • 17. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome.
    Schrage B, Duan G, Yang LP, Fraser JD, Proft T.
    Clin Infect Dis; 2006 Sep 15; 43(6):743-6. PubMed ID: 16912949
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic considerations for children with invasive group a streptococcal infections: a case series report and review of the literature.
    Burnett AM, Domachowske JB.
    Clin Pediatr (Phila); 2007 Jul 15; 46(6):550-5. PubMed ID: 17579110
    [No Abstract] [Full Text] [Related]

  • 19. Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation.
    Holm SE, Köhler W, Kaplan EL, Schlievert PM, Alouf JE, Stevens DL, Kotb M.
    Adv Exp Med Biol; 1997 Jul 15; 418():193-9. PubMed ID: 9331631
    [No Abstract] [Full Text] [Related]

  • 20. [Superantigens and toxic shock syndrome. A report of three cases treated with intravenous gammaglobulin].
    Vázquez García RE, Hernández Bautista V, Espinosa Padilla S.
    Rev Alerg Mex; 2006 Jul 15; 53(5):183-8. PubMed ID: 17357565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.